Results 111 to 120 of about 7,361 (221)
The Anti-Acetylcholine Receptor Antibody Test in Suspected Ocular Myasthenia Gravis
Journal of Ophthalmology, 2014 Aim. To estimate the clinical significance of anti-acetylcholine receptor antibody (anti-AChR-Ab) levels in suspected ocular myasthenia gravis. Methods. In total, 144 patients complaining of fluctuating diplopia and ptosis were evaluated for serum levels
Jung Jin Lee +2 more
doaj +1 more source
Distal Agrin (AGRN) Congenital Myasthenic Syndrome With Mitochondrial Dysfunction
European Journal of Neurology, Volume 33, Issue 7, July 2026.ABSTRACT Background Agrin‐congenital myasthenic syndrome (AGRN‐CMS) is a rare, heterogeneous genetic disorder of the neuromuscular transmission that can present from infancy to adulthood. The clinical phenotype includes distal weakness mimicking distal myopathies.
Mariana Manoel Oku +4 more
wiley +1 more source
Postintervention Status in Ocular Myasthenia Gravis: Effects of Treatment [PDF]
, 2011 Evidence-based strategy of treatment of ocular myasthenia gravis(OMG) is still not sufficient.
Xiaojun Zhang; Yun Jing; Shan Ma; Ningning Qin; Lei Yu; Ruiling Chen
core
Ocular Manifestations in Dogs With Facial Nerve Dysfunction
Veterinary Ophthalmology, Volume 29, Issue 4, July 2026.ABSTRACT Objective To characterize the spectrum and frequency of ocular abnormalities associated with facial nerve dysfunction (FND) in dogs and to assess clinical outcomes, with specific comparison between brachycephalic (BC) and non‐brachycephalic (NBC) breeds: Methods Medical records of dogs with FND evaluated between 2009 and 2023 at the ...
L. Gaztelu, M. Leiva, T. Peña, J. Ríos
wiley +1 more source
Ocular Myasthenia Gravis and Thymus Gland Hyperplasia–A Case Report
TNOA Journal of Ophthalmic Science and ResearchMyasthenia gravis (MG) is caused by antibodies directed at acetylcholine receptors or functionally related proteins in the postsynaptic membrane at the neuromuscular junction.
Sujit Das
doaj +1 more source
Juvenile Ocular Myasthenia Gravis: Risk of Generalization and Amblyopia [PDF]
, 2010 There have been only a few studies evaluating visual and systemic outcomes, such as amblyopia or systemic generalization, in pediatric ocular myasthenia gravis (OMG)
Heather E. Moss; Stacy L. Pineles; Grant T. Liu +1 more
core
Ocular Myasthenia Mimicking Third Nerve Palsy [PDF]
, 2015 66 year old man with ptosis OS and diplopia, slow saccades and pattern of a third nerve palsy. He shows a Cogan\u27s lid twitch. Differential diagnosis is cavernous sinus lesion vs myasthenia.
Jacqueline Winterkorn, MD, PhD (1947-2015)
core
OMGRATS: a new rating scale for Ocular Myasthenia Gravis [PDF]
, 2019 We present the first dedicated rating scale for Ocular Myasthenia Gravis (OMG), developed through an international collaboration between neuromuscular and neuro-ophthalmology experts in OMG.
Sui Wong; A. Xhepa; Eduardo Miranda; H. Lee; A. Burke; Laura Dell\u27Arti; Wayne Cornblath; Eric Eggenberger; Carolina Barnett
core
Mycophenolate Mofetil as First-Line Therapy for Ocular Myasthenia Gravis [PDF]
, 2011 Ocular myasthenia gravis (OMG) may produce debilitating diplopia or ptosis leading to significant visual disability. Symptomatic treatment with pyridostigmine is frequently ineffective and immunosuppressive therapy with corticosteroids can have serious ...
Lindsey De Lott; Aileen Antonio-Santos; Eric Eggenberger; Preston Calvert; Wayne Cornblath
core
Ocular Motor Dysfunction in Ocular Myasthenia Gravis: Effects of Treatment [PDF]
, 2005 The optimal treatment of the ophthalmoparesis associated with ocular myasthenia gravis (OMG) remains unknown. We evaluated the efficacy of prednisone and pyridostigmine in reducing diplopia and ocular motor dysfunction in patients with ...
Mark J. Kupersmith; Gui-shuang Ying
core